US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Ofloxacin Ophthalmic Solution

Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

PACK Pharmaceuticals, LLC NDC 16571-130-11 D-1069-2014
Class III · Low risk Terminated

Ofloxacin Ophthalmic Solution

Reason Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

PACK Pharmaceuticals, LLC NDC 16571-130-50 D-1068-2014
Class III · Low risk Terminated

Derma-Smoothe/FS

Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Hill Dermaceuticals, Inc. NDC 28105-150-04 D-008-2014
Class III · Low risk Terminated

Derma-Smoothe/FS

Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Hill Dermaceuticals, Inc. NDC 28105-149-04 D-007-2014
Class III · Low risk Terminated

Loratadine

Reason Failed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.

Novartis Consumer Health D-022-2014
Class III · Low risk Terminated

Hydrocodone Bitartrate and Acetaminophen Tablets

Reason Defective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.

Watson Laboratories Inc NDC 0591-2611-05 D-1061-2013
Class III · Low risk Terminated

SPIRIVA HandiHaler

Reason Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler

Boehringer Ingelheim Roxane Inc NDC 0597-0075-27 D-1057-2013
Class III · Low risk Terminated

buPROPion Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets (XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.

Actavis South Atlantic LLC NDC 67767-142-30 D-917-2013
Class III · Low risk Terminated

Introvale

Reason Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Sandoz Incorporated NDC 0781-5584-36 D-854-2013
Class III · Low risk Terminated

Maalox Nighttime Antacid with Acid Reflux Barrier

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-910-2013
Class III · Low risk Terminated

Maalox Nighttime Antacid with Acid Reflux Barrier

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-909-2013
Class III · Low risk Terminated

Maalox Extra Strength Antacid with Anti-Gas

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-908-2013
Class III · Low risk Terminated

Maalox

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-907-2013
Class III · Low risk Terminated

Maalox Extra Strength Antacid

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-906-2013
Class III · Low risk Terminated

Maalox Advanced Maximum Strength Antacid & Antigas

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health NDC 0067-6279-35 D-905-2013
Class III · Low risk Terminated

Maalox Advanced Maximum Strength Antacid & Antigas

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-904-2013
Class III · Low risk Terminated

Maalox Regular Strength Antacid

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-903-2013
Class III · Low risk Terminated

Maalox Extra Strength Antacid with Anti-Gas

Reason Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Novartis Consumer Health D-902-2013
Class III · Low risk Terminated

Mavik¿ trandolapril tablets 4mg

Reason Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

AbbVie Inc. D-901-2013
Class III · Low risk Terminated

BuPROPion Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.

Actavis Inc NDC 67767-142-30 D-855-2013
Class III · Low risk Terminated

Clobetasol Propionate Cream

Reason Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

Hi-Tech Pharmacal Co., Inc. NDC 50383-267-15 D-888-2013
Class III · Low risk Terminated

Tagitol V Barium Sulfate Suspension

Reason Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

Bracco Diagnostics Inc NDC 32909-814-53 D-914-2013
Class III · Low risk Terminated

Oxycodone and Acetaminophen Capsules

Reason Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.

Watson Laboratories Inc NDC 0591-0737-01 D-823-2013
Class III · Low risk Terminated

Tums

Reason Presence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tablets

GlaxoSmithKline, LLC. NDC 0135-0181-02 D-850-2013